| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/27/2000 | EP1037976A1 Single-chain polypeptides comprising troponin i and troponin c |
| 09/27/2000 | EP1037974A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
| 09/27/2000 | EP1037970A1 Secreted proteins and polynucleotides encoding them |
| 09/27/2000 | EP1037965A1 Methods for preparation of vaccines against cancer |
| 09/27/2000 | EP1037963A1 CRYSTAL COMPRISING HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN gp120, COMPOUNDS INHIBITING CD4-gp120 INTERACTION, COMPOUNDS INHIBITING CHEMOKINE RECEPTOR-gp120 INTERACTION, MIMICS OF CD4 AND gp120 VARIANTS |
| 09/27/2000 | EP1037927A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 09/27/2000 | EP1037925A2 Antagonists of neuropilin receptor functional and use thereof |
| 09/27/2000 | EP1037924A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna |
| 09/27/2000 | EP1037923A1 Method for preparing by filtration a virally secure factor viii solution |
| 09/27/2000 | EP1037922A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 09/27/2000 | EP1037921A1 Erythropoietin with high specific activity |
| 09/27/2000 | EP1037920A1 Molecules associated with the human suppressor of fused gene |
| 09/27/2000 | EP1037919A1 Proteins for cancer cell specific induction of apoptosis and method for isolation thereof |
| 09/27/2000 | EP1037917A1 Recombinant nodavirus compositions and methods |
| 09/27/2000 | EP1037916A2 Erythrovirus and its applications |
| 09/27/2000 | EP1037915A1 Matrix-remodeling genes |
| 09/27/2000 | EP1037914A2 Mammalian calcitonin-like polypeptide-1 |
| 09/27/2000 | EP1037913A1 Galanin receptor galr3 and nucleotides encoding same |
| 09/27/2000 | EP1037912A1 DNA MOLECULES ENCODING VERTEBRATE NUCLEAR RECEPTOR PROTEIN, nNR4 |
| 09/27/2000 | EP1037911A1 Anti-pathogen system and methods of use thereof |
| 09/27/2000 | EP1037910A2 Maintenance of smooth muscle integrity by morphogenic proteins |
| 09/27/2000 | EP1037909A2 Postweaning multisystemic wasting syndrome virus from pigs |
| 09/27/2000 | EP1037908A2 Human tumor necrosis factor-r2-like proteins |
| 09/27/2000 | EP1037907A2 Bone morphogenetic protein (bmp) -17 and bmp-18 and compositions thereof |
| 09/27/2000 | EP1037902A1 Novel tgf-beta protein purification methods |
| 09/27/2000 | EP1037901A1 Mammaglobin, a secreted mammary-specific breast cancer protein |
| 09/27/2000 | EP1037900A1 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 09/27/2000 | EP1037899A1 Secreted proteins and polynucleotides encoding them |
| 09/27/2000 | EP1037898A1 Secreted proteins |
| 09/27/2000 | EP1037669A1 Therapeutic use of lentiviral vectors |
| 09/27/2000 | EP1037661A1 ribH |
| 09/27/2000 | EP1037660A1 ribB |
| 09/27/2000 | EP1037658A1 Ifnar2/ifn complex |
| 09/27/2000 | EP1037657A1 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 09/27/2000 | EP1037656A1 Lymphotactin as an adjuvant |
| 09/27/2000 | EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 09/27/2000 | EP1037654A1 ribA |
| 09/27/2000 | EP1037650A1 Methods and compositions for the treatment and prevention of staphylococcus aureus infections |
| 09/27/2000 | EP1037603A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 09/27/2000 | EP1037537A1 A process for preparing a kappa-caseino glycomacropeptide or a derivative thereof |
| 09/27/2000 | EP1037533A1 Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases |
| 09/27/2000 | EP1037530A1 ribG |
| 09/27/2000 | EP0805819A4 Chimeric dna-binding proteins |
| 09/27/2000 | EP0778890B1 Dna encoding a human calcium channel alpha-1e subunit |
| 09/27/2000 | EP0764170B1 Branched synthetic peptide conjugate |
| 09/27/2000 | EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 09/27/2000 | EP0688224B1 A mutant crp-protein and methods and materials for making and using it |
| 09/27/2000 | EP0648260B1 Fusobacterium necrophorum leukotoxoid vaccine |
| 09/27/2000 | CN1268183A Male tissue-perferred regulatory region and method of using same |
| 09/27/2000 | CN1268182A RANK1, an ankyrin-repeat containing peptide from rice associated with disease resistance |
| 09/27/2000 | CN1268180A Broad-spectrum delta-endotoxins |
| 09/27/2000 | CN1268179A Microbial swollenin protein, DNA sequences encoding such swollenins and method of producing such swoolenins |
| 09/27/2000 | CN1268177A Novel nucleic acid molecules and uses therefor |
| 09/27/2000 | CN1268175A Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 09/27/2000 | CN1268141A Recombinant expression of insulin C-peptide |
| 09/27/2000 | CN1267730A New human potassium ion passage regulating factor protein and its code sequence |
| 09/27/2000 | CN1267729A New human macroglycoprotein relating protein and its code sequence |
| 09/27/2000 | CN1267728A New human sexual differentiation determining factor protein and its code sequence |
| 09/27/2000 | CN1267727A New human phosphorylated zymoprotein of pyruvate dehydrogenase and its code sequence |
| 09/27/2000 | CN1267726A New human zinc-finger protein and its code sequence |
| 09/27/2000 | CN1056881C Insecticidal protein-encoding gene, gramineous plants transformed with the gene, and production thereof |
| 09/27/2000 | CN1056880C Synthetic insecticidal crystal protein gene |
| 09/27/2000 | CN1056879C 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
| 09/27/2000 | CN1056878C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 09/27/2000 | CN1056851C Cyclic adhesion inhibitors |
| 09/26/2000 | US6124449 High affinity TGFβ nucleic acid ligands and inhibitors |
| 09/26/2000 | US6124448 Nucleic acid primers and probes for the mammalian OB gene |
| 09/26/2000 | US6124447 Nucleic acid sequence coding protein which serves as a substrate for cathepsins and has a enzymatic activity which releases phosphoric acid from preferential proteins; for use as an insecticide |
| 09/26/2000 | US6124446 Polynucleotide sequence coding a vacuolar separation polypeptide; for the diagnosis, treatment, and prevention of cancer, inflammatory, lysosomal storage and membrane transport defects; anticarciongenic agents |
| 09/26/2000 | US6124439 OB polypeptide antibodies and method of making |
| 09/26/2000 | US6124438 Receptor protein which preferentially binds to neuronal tissues; for detection of injury to animal neuronal tissues |
| 09/26/2000 | US6124436 Purified mammalian monocyte antigens and related reagents |
| 09/26/2000 | US6124435 Carbohydrate-directed cross-linking reagents |
| 09/26/2000 | US6124434 Human protein capable of adjustments in yeast; for the diagnosis, treatment and detection of cancer and cell proliferation defects; antitumor agents; anticarcinogenic agents |
| 09/26/2000 | US6124433 Polypeptide for use in the detection and monitoring of atherosclerosis, ischemia, hypertension, restenosis, and arterial inflammation |
| 09/26/2000 | US6124432 Bringing dermonecrotic toxin-containing solution into contact with chromatographic gel sulfated by direct sulfation or a chromatographic gel to which a sulfated molecule is covalently bonded to thereby adsorb dermonecrotic toxin on gel, eluting |
| 09/26/2000 | US6124430 Amino acid squences useful as a reagent in an immunoassay for measuring and detection of heart hormone protein |
| 09/26/2000 | US6124429 Fibrous protein to be used as biocompatible polymer for surgical sutures, artificial blood vessels and artificial tissues |
| 09/26/2000 | US6124267 O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1 |
| 09/26/2000 | US6124265 Method of making and cross-linking keratin-based films and sheets |
| 09/26/2000 | US6124262 Compositions and methods for reducing adhesiveness of defective red blood cells |
| 09/26/2000 | US6124260 Inhibition of smooth muscle cell migration by Tenascin-C peptides |
| 09/26/2000 | US6124258 Heat resistant, sterilized carbonic acid-iron-casein complex lacking astringent taste; antianemia agents |
| 09/26/2000 | US6124255 Preparation comprising thiol-group-containing proteins |
| 09/26/2000 | US6124131 Protein associated with incresed oxygen demand; for treatment and prevention of tissues damage caused by lack of oxygen |
| 09/26/2000 | US6124128 Nucleic acid coding green fluorescent protein; for use as marker of gene expression, tracers of cell lineage and as fusion tags to monitor protein localization within viable cells |
| 09/26/2000 | US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides |
| 09/26/2000 | US6124118 Receptor recognition factors, protein sequences and methods of use thereof |
| 09/26/2000 | US6124117 Polysaccharide binding fusion proteins and conjugates |
| 09/26/2000 | US6124116 Nucleotide sequence coding human guanidine triphosphatase; for the diagnosis, prevention, or treatment of vision defects, acquired immune deficiency syndrome, and cancer; anticarcinogenic agents |
| 09/26/2000 | US6124114 Nucleotide sequences coding globin like polypeptides; for use as blood replacements |
| 09/26/2000 | US6124113 Fermentative carotenoid production |
| 09/26/2000 | US6124107 Screening for fibrinogen cleavage peptides in a sample of a body fluid; mixing sample with anticoagulent, centrifuging, recovering supernatant, incubate with antibodies, screening for antibody/peptide complex |
| 09/26/2000 | US6124105 Method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein |
| 09/26/2000 | US6124104 Chromosome 13-linked breast cancer susceptibility gene |
| 09/26/2000 | US6124101 Diagnosis of thrombosis in a mammals; incubating a sample of fluid with an antibody that preferentially binds a cleaved activation peptide, counting antibody bound cleaved activation peptides, compare to control |
| 09/26/2000 | US6123949 A vaccine which comprises an effective immunizing amount of the genetically engineered fowlpox virus designated s-fpv-043, useful for immunizing the animal against disease caused by fowlpox virus and newcastle disease virus |
| 09/26/2000 | US6123948 Antigenic determinants of atleast two human papilloma virus proteins selected from l1, l2, e1, e2, e3, e4, e5, e6, e7, in amorphous reaggregated form which when in solution can pass through a sterillization filter used as immunogenic |
| 09/26/2000 | US6123942 Bacterial hemoglobin receptor gene |
| 09/26/2000 | US6123938 Human urinary hyaluronidase |